Ziresovir's Phase III results mark a significant milestone, representing the first clinical validation of an antiviral's ...

Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our infants with vaccination.

Roughly 8000 Brits died from respiratory syncytial virus infections last year, with tens of thousands likely clogging up ...

Clinical trials have shown that the RSV vaccine reduces symptoms by around 80 per cent, significantly lowering the risk of ...

While most infants affected by RSV experience mild symptoms and do not require hospitalisation, certain groups are at a higher risk for severe illness. Infants under six months are particularly ...

Learn more about similarities and differences in symptoms, prevention, and other key aspects between RSV and coronavirus. You can get RSV at any age, but it's most common in infants and children ...

The Ministry of Public Health (MoPH) has advised the public, especially the vulnerable to take the Respiratory Syncytial ...

ATLANTA (AP) — A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new ...

caused by RSV in infants from birth through 6 months of age following maternal immunization during pregnancy "We are thrilled that ABRYSVO is now approved in the EU to help prevent RSV in adults ...

The Department of Health has announced that the jab would be more widely available as part of a wider package of preventative ...